Samuel Yeroushalmi

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (4)

• Comparing the odds of reported depression in psoriasis patients on systemic therapy: a cross-sectional analysis of postmarketing data
  Journal of Dermatological Treatment 2023 DOI: 10.1080/09546634.2022.2152272
  +Save
• Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic Survival
  Edward Kenji Hadeler, Sugandh Kumar, Samuel Yeroushalmi +14 more
  Journal of Psoriasis and Psoriatic Arthritis 2023 DOI: 10.1177/24755303221131259
  +Save
• Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS)
  JAAD International 2022 DOI: 10.1016/j.jdin.2022.08.010
  +Save
• Dietary Intervention and Supplements in the Management of Psoriasis: Current Perspectives
  Psoriasis: Targets and Therapy 2022 DOI: 10.2147/PTT.S328581
  +Save